申请人:E.R. Squibb & Sons, Inc.
公开号:EP0206540A1
公开(公告)日:1986-12-30
Vasodilating activity is exhibited by new compounds having the formula
or a pharmaceutically acceptable salt thereof wherein
n is 2 or 3; X is oxygen or sulfur;
R, and R2 are each independently hydrogen, alkyl, cycloalkyl, or allyl, or R, and R2 together with the nitrogen atom to which they are attached are pyrrolidinyl, piperidinyl, or morpholinyl;
R3 is alkyl, alkoxy, halogen, trifluoromethyl, or nitro;
R4 is hydrogen, halogen, trifluoromethyl, or nitro; and
R5 and R6 are each independently alkyl or cycloalkyl or R5 and R6 together with the nitrogen atom to which they are attached are pyrrolidinyl, piperidinyl, or morpholinyl.
具有以下式子的新化合物具有血管扩张活性
或其药学上可接受的盐,其中
n为2或3; X为氧或硫;
R和R2各自独立地是氢、烷基、环烷基或烯丙基,或R和R2连同它们所连接的氮原子是吡咯烷基、哌啶基或吗啉基;
R3 是烷基、烷氧基、卤素、三氟甲基或硝基;
R4 是氢、卤素、三氟甲基或硝基;以及
R5 和 R6 各自独立地为烷基或环烷基,或 R5 和 R6 与它们所连接的氮原子一起为吡咯烷基、哌啶基或吗啉基。